Dergiler / Göztepe Tıp Dergisi / 2010 / Cilt: 25 - Sayı: 1

Yüksek evreli gliomlarda radyoterapiye eşlik eden temozolamid tedavisi ve psödoprogresyon kavramı

Temozolamide treatment and pseudoprogression description accompanies radiotheraphy on high grade glioma

Sayfa
43–47
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We aimed to explain this new condition with a casethat we assumed as pseudoprogression having high degreeglioma.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:High grade gliomas need serious follow up in post operativeperiod.
📊
Temel Bulgular & Veri:It might be necessary to re-operate due to tumor progression in this period.
💡
Sonuç & Katkı:We aimed to explain this new condition with a casethat we assumed as pseudoprogression having high degreeglioma.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

High grade gliomas need serious follow up in post operativeperiod. It might be necessary to re-operate due to tumor progression in this period. In addition, some changes because ofradiotherapy and chemotherapy might act like tumor progression. This condition is called pseudoprogression and its mana- gement is different. Therefore pseudoprogression is a newcondition that should be known and considered via followingup high grade gliomas. Studies for this subject increase in literature. We aimed to explain this new condition with a casethat we assumed as pseudoprogression having high degreeglioma.

🔖

Bu Makaleye Atıf Yap

SARI, R., BÖLÜKBAŞI, F. H., ELMACI, İ., AYAN, E. (2022). Yüksek evreli gliomlarda radyoterapiye eşlik eden temozolamid tedavisi ve psödoprogresyon kavramı. Göztepe Tıp Dergisi, Cilt: 25 - Sayı: 1, 43–47. https://ajindex.com/articles/526182

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Brandes AA, Tosoni A, Spagnolli F, et al. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology. Neuro Oncol 2008;10:361-367
  2. Chamberlain MC. Pseudoprogression in Glioblastoma. Journal of Clinical Oncology 2008;10:4359-4362
  3. Stupp R, Mason WP, Bent MJ, et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 2005;352:987-996
  4. Koukourakis GV, Kouloulias V, Zacharias G, et al. Temozolomide with Radiation Therapy in High Grade Brain Gliomas: Pharmaceuticals Considerations and Efficacy; A Review Article. Molecules 2009;14:1561-1577
  5. Brandsma D, Stalpers L, Taal W, et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008;9:453-61
  6. Chamberlain MC, Glantz MJ, Chalmers L, et al. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 2006;82:81-83
  7. Brandes AA, Franceschi E, Tosoni A, et al. MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomi tant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients. J Clin Oncol 2008;26(13):2192-7
  8. Taal W, Brandsma D, Bruin HG, et al. Incidence of Early Pseudo-progression in a Cohort of Malignant Glioma Patients Treated With Chemoirradiation With Temozolomide. Cancer 2008;113(2):405-10
  9. Kumar AJ, Leeds NE, Fuller GN, et al. Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy- and Chemotherapy-induced Necrosis of the Brain after Treatment. Radiology 2000;217(2):377-384
  10. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomied phase III study: 5-year analysis of the EORTC-NCIC trial: Lancet Oncol 2009;10(5):459-66.